BioCentury
ARTICLE | Clinical News

Auriclosene: Phase IIb start

December 23, 2013 8:00 AM UTC

Next year, NovaBay said it will begin evaluating an optimized formulation of auriclosene to treat patients with impetigo. In November, NovaBay reported that a topical gel formulation of auriclosene mi...